Michael L. Olson

发表

Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma.

A. Koong, D. Bouley, N. Denko, 2011, Blood.

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing fratricide and antigen-negative tumor escape while preserving anti-tumor activity

T. Luetkens, D. Atanackovic, A. Welm, 2021, bioRxiv.

Role of immunotherapy in Ewing sarcoma

T. Luetkens, D. Atanackovic, Michael L. Olson, 2020, Journal for ImmunoTherapy of Cancer.

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

T. Luetkens, D. Atanackovic, Michael L. Olson, 2019, Oncoimmunology.

Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways.

S. Kridel, A. Koong, Jiangbin Ye, 2008, Cancer research.

Targeting the tumor microenvironment of Ewing sarcoma.

T. Luetkens, D. Atanackovic, Michael L. Olson, 2021, Immunotherapy.

Fast off-rate CD229 chimeric antigen receptor T cells efficiently target multiple myeloma, spare T cells, and exhibit reduced trogocytosis

David P Ng, J. Panse, T. Luetkens, 2021 .

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide

J. Panse, T. Luetkens, D. Atanackovic, 2020, Nature Communications.

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion

T. Luetkens, D. Atanackovic, A. Welm, 2022, Leukemia.

The role of surface molecule CD229 in Multiple Myeloma.

T. Luetkens, D. Atanackovic, Michael L. Olson, 2019, Clinical immunology.

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide

J. Panse, T. Luetkens, D. Atanackovic, 2020, Nature Communications.

Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells

A. Letai, J. Ryan, Michael L. Olson, 2023, Cell death & disease.